
The Need: Currently available and commonly used “hemostats are beneficial for treating minor surgical bleeding but ineffective for use in trauma to control life threatening hemorrhage seen in combat casualties. Therefore, there
is a need for a highly effective, bio-absorbable hemostatic dressing that can be used safely to control internal hemorrhage in damage control operations and fill this capability gap in our combat support hospitals.”*
Conclusion: The results of the study on the STB-FAST technology “indicate a superior hemostatic efficacy of the FAST dressing that surpasses any other known hemostatic agent… In our opinion, it is a giant leap forward in
hemorrhage control therapy which could potentially benefit both prehospital and in-hospital (surgical) care of combat casualties where no other means is effective or practical.”*
*Source: The U.S. Army Institute of Surgical Research Assessment Report (2014)